On Thursday 20 August 2026, COFEPRIS published the Visor de Registros Sanitarios de Dispositivos Médicos — a public lookup of vigente (active) sanitary registrations for medical devices granted by the commission. The press piece is Comunicado de prensa 21/2026 (Ciudad de México, 20 de agosto de 2026). The tool itself sits at registros.cofepris.gob.mx/BRSDM.
If your Mexico launch memo still says “ask the distributor for a copy of the registro,” rewrite it. You can now check the named titular yourself, against a government source that updates continuously.
What the visor is — and what it is not
COFEPRIS frames the visor as part of the Plan Nacional de Autonomía Digital. Implementation is two-stage. The public and health institutions can consult and verify active sanitary registrations granted by COFEPRIS. Only records that comply with applicable legal provisions are included. The platform is dynamic: continuous updates, not a one-shot PDF dump.
Read that carefully. The visor is a public lookup of active device registrations. It does not issue a new Registro Sanitario. It does not replace a COFEPRIS application. It is not a clinical-trial database. Do not put “visor screenshot” on a board slide as if it were your authorization to sell.
Trade coverage followed a few days later (Mexico Business News, 24 August 2026). Prefer the official gob.mx cite when you brief counsel or a distributor. Secondary write-ups are useful for awareness; they are not the primary instrument.
Why the named titular matters more than the PDF
Mexico market access for commercial devices still lives or dies on who holds the Registro Sanitario — the titular / marketing registration holder (MRH). The visor makes that name checkable in public, for records COFEPRIS has placed in the vigente set.
That changes diligence:
- Independent holder vs distributor-holder. If your Mexican distributor is the titular, they control the sanitary face of the product. Channel termination does not automatically move the certificate. If a neutral Mexican company holds the registro, you can change sales partners without restarting the file as a hostage negotiation.
- Public verify before LOI. Ask for the registration number, then open the visor. Confirm the product description, the vigente status, and the named holder match the story in the LOI. Do not treat a scanned PDF from the partner’s shared drive as the only evidence.
- Hospital and tender questions. Health institutions are an explicit audience in Comunicado 21/2026. Expect purchasing and clinical-engineering teams to use the same public check. Your sales deck should match what they will see.
This is the same titular discipline bioaccess® uses across LATAM registration and importer-of-record work. Mexico’s visor simply makes the holder name harder to hand-wave.
Stage 1: titulares have a two-week observation window
Comunicado 21/2026 is explicit on stage one. Titulares of sanitary registrations may send observations, per registro, on the information shown in the visor. Use the corresponding request format and send it to digipris@cofepris.gob.mx within two weeks of the announcement.
If you are the titular — or you control the Mexican company that is — treat that clock as operational, not optional. Wrong brand name, wrong model string, or a stale legal-entity display creates downstream tender and customs friction even when the underlying authorization is fine. Log which registros you reviewed, which observations you filed, and who owns the reply from DIGIPRIS.
If your “Mexico partner” is the titular and they ignore stage one, that is a signal about how they will handle variations and tecnovigilancia later. Put it in the risk memo.
Independent holder vs distributor-holder — decide before freight
U.S. and EU teams still sign Mexico distribution first and “sort registration later.” The visor makes the cost of that sequence visible. Before you book a launch quarter, lock four roles:
- Who is the COFEPRIS titular. The legal face on the vigente registration the visor will show. Manufacturer’s Mexican branch, independent Mexican holder, or distributor-as-holder — pick one on purpose.
- Who is the commercial importer of record. Freight paperwork has to align with the authorized structure. A forwarder with a borrowed tax ID is not a sanitary plan.
- Who files tecnovigilancia and field actions. Adverse-event and safety reporting for registered devices is a local sanitary duty, not a U.S. mailbox that “will translate later.”
- Who owns variations. Model adds, software bumps, and sterile-barrier changes need a Mexican variation path once registro exists. Quiet EU updates do not auto-propagate into the visor.
Distributor-as-titular is easy to sign and hard to unwind. Independent-holder structures cost more upfront and keep the certificate movable when the channel breaks. bioaccess®’s public market access / LATAM Launch SKU ($7,500/year) exists for teams that want the all-in holder model across LATAM rather than a one-country PDF chase — Mexico’s visor is exactly why “distributor-only” plans break under diligence.
FIH in Mexico is a different workstream
A first-in-human or early-feasibility investigation in Mexico and a commercial Registro Sanitario are different files. Do not clear investigational units on a commercial registration number that does not cover the investigational configuration, and do not tell the hospital that “the visor shows we are registered, so ethics is optional.” Ethics and COFEPRIS clinical pathways keep their own calendars. Say it once and keep the columns separate on the Gantt: trial authorization on one side, commercial registro and titular on the other.
Where teams burn quarters after Comunicado 21/2026
- Treating the visor as the application desk. It verifies vigente records. It does not replace a Registro Sanitario filing.
- Accepting a distributor PDF without a public check. Open the visor. Match number, product, holder, and status to the commercial story.
- Leaving stage-one observations to “the local guy.” Two weeks from the 20 August 2026 announcement is a named window. Unfiled corrections become tender friction.
- Mixing FIH kits with commercial registro language. Investigation and selling licenses are not the same sentence, even when both mention COFEPRIS.
- Assuming every historical registration appears. COFEPRIS says only records that comply with applicable legal provisions are included, with continuous updates. Absence from the visor is a question for the titular and DIGIPRIS — not proof that a private scan is enough.
How this beats generic “Mexico registration” posts
Most content posts on Mexico device registration still recycle secondary summaries: agency overview, class language, and a soft CTA to “talk to our consultants.” Comunicado 21/2026 gives operators a primary government citation and a live URL. Use it.
When you brief a board or a hospital system, cite the gob.mx article, name the visor URL, and show the titular check you ran. That is stronger than a slide that paraphrases a consulting firm’s evergreen Mexico page. Emergo-, MedEnvoy-, and Pure Global-style explainers can still be useful background. They are not a substitute for the commission’s own announcement of a public vigente lookup.
Transparency and digitization are the framing COFEPRIS chose. Your job as sponsor is narrower: confirm the holder you think you hired is the holder the public record shows, and fund the structure that keeps that name under your control.
One-page Mexico gate this week
- List every SKU you intend to sell in Mexico in the next 24 months.
- For each SKU with an existing registro claim, open the COFEPRIS visor and record: registration number, vigente status, named titular, date checked.
- For each “yes, vigente,” name: commercial IOR, tecnovigilancia owner, variation owner — three lines, three document IDs.
- If you are the titular (or control the titular entity), file stage-one observations to digipris@cofepris.gob.mx within the two-week window using the corresponding request format — per registro.
- Separate the FIH/EFS column if you also plan Mexican patients. Different dossier, different importer, different accountability log.
- Keep the official cite in the diligence pack: gob.mx / COFEPRIS Comunicado 21/2026.
If those owners cannot point to the same intended-purpose sentence in Spanish, you are not ready to quote Mexican hospital revenue. For the all-in holder model across LATAM, see bioaccess® market access / LATAM Launch — Mexico’s public visor is why “we will get the PDF from the distributor” is no longer a plan.